Allena Pharmaceuticals ($ALNA) #IPO Preview
Company: Allena Pharmaceuticals, Inc. Symbol: ALNA Description: They are a late-stage clinical biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders. Shares: 5.3 million Price Range: $14.00-$16.00 Trade Date: 11/2 Underwriter(s): Credit Suisse, Jefferies, Cowen & Company Co-Manager(s): Wedbush PacGrow Link to[…]